Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Almasilate
2. Aluminum Magnesium Silicate (mg(alsio4)2)
3. Magnesium Aluminosilicate
4. Magnesium Aluminum Silicate
5. Malinal
6. Neusilin Us2
7. Veegum
1. Veegum
2. 12511-31-8
3. Aluminum;magnesium;silicate
4. Magnesium Aluminate Metasilicate
5. Neusilin
6. Angast
7. Neusilin Us2
8. Neusilin Fh 2
9. Neusilin Fl 2
10. Neusilin Ufl 2
11. Magnesium Aluminum Silicate (mgal2(sio4)2)
12. Aluminium Magnesium Silicate
13. Unii-7to1453rtl
14. Einecs 235-682-0
15. Aluminium Magnesium Silicate(2:1:2)
16. Magnesium Aluminosilicate (mgal2si2o8)
17. Aluminosilicic Acid (halsio4), Magnesium Salt
18. Silicic Acid (h4sio4), Aluminum Magnesium Salt (2:2:1)
Molecular Weight | 143.37 g/mol |
---|---|
Molecular Formula | AlMgO4Si+ |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 0 |
Exact Mass | 142.9231651 g/mol |
Monoisotopic Mass | 142.9231651 g/mol |
Topological Polar Surface Area | 92.2 Ų |
Heavy Atom Count | 7 |
Formal Charge | 1 |
Complexity | 19.1 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12893
Submission : 1998-03-09
Status : Active
Type : IV
Registration Number : 221MF10093
Registrant's Address : 55 Yokohoonji, Kamiichi-cho, Nakaniikawa-gun, Toyama Prefecture
Initial Date of Registration : 2009-05-13
Latest Date of Registration :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26315
Submission : 2012-08-10
Status : Active
Type : IV
Registration Number : 218MF10858
Registrant's Address : 55 Yokohoonji, Kamiichi-cho, Nakaniikawa-gun, Toyama Prefecture
Initial Date of Registration : 2006-11-06
Latest Date of Registration :
Registration Number : 221MF10095
Registrant's Address : 55 Yokohoonji, Kamiichi-cho, Nakaniikawa-gun, Toyama Prefecture
Initial Date of Registration : 2009-05-13
Latest Date of Registration :
Registration Number : 221MF10096
Registrant's Address : 55 Yokohoonji, Kamiichi-cho, Nakaniikawa-gun, Toyama Prefecture
Initial Date of Registration : 2009-05-13
Latest Date of Registration :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12893
Submission : 1998-03-09
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26315
Submission : 2012-08-10
Status : Active
Type : IV
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Excipients by Applications
Market Place
ABOUT THIS PAGE
97
PharmaCompass offers a list of Aluminum Magnesium Silicate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Aluminum Magnesium Silicate manufacturer or Aluminum Magnesium Silicate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Aluminum Magnesium Silicate manufacturer or Aluminum Magnesium Silicate supplier.
PharmaCompass also assists you with knowing the Aluminum Magnesium Silicate API Price utilized in the formulation of products. Aluminum Magnesium Silicate API Price is not always fixed or binding as the Aluminum Magnesium Silicate Price is obtained through a variety of data sources. The Aluminum Magnesium Silicate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Neusilin US2 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Neusilin US2, including repackagers and relabelers. The FDA regulates Neusilin US2 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Neusilin US2 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Neusilin US2 supplier is an individual or a company that provides Neusilin US2 active pharmaceutical ingredient (API) or Neusilin US2 finished formulations upon request. The Neusilin US2 suppliers may include Neusilin US2 API manufacturers, exporters, distributors and traders.
click here to find a list of Neusilin US2 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Neusilin US2 DMF (Drug Master File) is a document detailing the whole manufacturing process of Neusilin US2 active pharmaceutical ingredient (API) in detail. Different forms of Neusilin US2 DMFs exist exist since differing nations have different regulations, such as Neusilin US2 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Neusilin US2 DMF submitted to regulatory agencies in the US is known as a USDMF. Neusilin US2 USDMF includes data on Neusilin US2's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Neusilin US2 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Neusilin US2 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Neusilin US2 Drug Master File in Japan (Neusilin US2 JDMF) empowers Neusilin US2 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Neusilin US2 JDMF during the approval evaluation for pharmaceutical products. At the time of Neusilin US2 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Neusilin US2 suppliers with JDMF on PharmaCompass.
Neusilin US2 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Neusilin US2 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Neusilin US2 GMP manufacturer or Neusilin US2 GMP API supplier for your needs.
A Neusilin US2 CoA (Certificate of Analysis) is a formal document that attests to Neusilin US2's compliance with Neusilin US2 specifications and serves as a tool for batch-level quality control.
Neusilin US2 CoA mostly includes findings from lab analyses of a specific batch. For each Neusilin US2 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Neusilin US2 may be tested according to a variety of international standards, such as European Pharmacopoeia (Neusilin US2 EP), Neusilin US2 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Neusilin US2 USP).